Previvor Edge Raises $3.3M to Shift Cancer Care From Reactive to Proactive

▤ Summary

Previvor Edge raised $3.3 million in an oversubscribed pre-seed round to expand its cancer prevention platform. The company combines digital intake, genetic testing, clinician review, and personalized 12-month care plans to move cancer care from reactive to proactive. It already has clinical programs in-network with major insurers and says most patients change their prevention or detection strategy after enrollment. The company is also pursuing referrals, waitlist growth, and white-label partnerships with health systems.

$ Funding

▦ Linked Companies